OR5P2
gene geneOn this page
Also known as JCG3
Summary
OR5P2 (olfactory receptor family 5 subfamily P member 2, HGNC:14783) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 5P2 (Q8WZ92). Odorant receptor (Potential).
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 120065 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 45 total
- MANE Select transcript:
NM_153444
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14783 |
| Approved symbol | OR5P2 |
| Name | olfactory receptor family 5 subfamily P member 2 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | JCG3 |
| Ensembl gene | ENSG00000183303 |
| Ensembl biotype | protein_coding |
| Entrez | 120065 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000329434
RefSeq mRNA: 1 — MANE Select: NM_153444
NM_153444
CCDS: CCDS7782
Canonical transcript exons
ENST00000329434 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001324685 | 7795974 | 7796942 |
Expression profiles
Bgee: expression breadth tissue_specific, 7 present calls, max score 44.67.
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 44.67 | silver quality |
| skin of abdomen | UBERON:0001416 | 42.31 | gold quality |
| zone of skin | UBERON:0000014 | 40.64 | gold quality |
| bone marrow cell | CL:0002092 | 39.61 | gold quality |
| skin of leg | UBERON:0001511 | 38.93 | gold quality |
| tonsil | UBERON:0002372 | 38.84 | gold quality |
| granulocyte | CL:0000094 | 37.25 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| urinary bladder | UBERON:0001255 | 33.62 | silver quality |
| bone marrow | UBERON:0002371 | 33.50 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| right uterine tube | UBERON:0001302 | 33.22 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| fundus of stomach | UBERON:0001160 | 28.91 | silver quality |
| liver | UBERON:0002107 | 28.84 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| leukocyte | CL:0000738 | 28.12 | gold quality |
| right coronary artery | UBERON:0001625 | 27.66 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.61 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 27.56 | gold quality |
| monocyte | CL:0000576 | 27.54 | gold quality |
| placenta | UBERON:0001987 | 27.51 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
44 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or5p76 | ENSMUSG00000058014 |
| mus_musculus | Or5p78 | ENSMUSG00000058244 |
| mus_musculus | Or5p58 | ENSMUSG00000059031 |
| mus_musculus | Or5p79 | ENSMUSG00000061000 |
| mus_musculus | Or5p59 | ENSMUSG00000078118 |
| mus_musculus | Or5p68 | ENSMUSG00000093980 |
| mus_musculus | Or5p6 | ENSMUSG00000094426 |
| mus_musculus | Or5p72 | ENSMUSG00000095239 |
| mus_musculus | Or5p50 | ENSMUSG00000095910 |
| mus_musculus | Or5p63 | ENSMUSG00000095929 |
| mus_musculus | Or5p62 | ENSMUSG00000096068 |
| mus_musculus | Or5p81 | ENSMUSG00000096209 |
| mus_musculus | Or5p64 | ENSMUSG00000096465 |
| mus_musculus | Or5p73 | ENSMUSG00000096679 |
| mus_musculus | Or5p61 | ENSMUSG00000108995 |
| mus_musculus | Or5p67 | ENSMUSG00000109497 |
| mus_musculus | Or5p51 | ENSMUSG00000109542 |
| mus_musculus | Or5p69 | ENSMUSG00000109631 |
| mus_musculus | Or5p66 | ENSMUSG00000109884 |
| mus_musculus | Or5p60 | ENSMUSG00000110171 |
| mus_musculus | Or5p70 | ENSMUSG00000110253 |
| rattus_norvegicus | Or5p68 | ENSRNOG00000009748 |
| rattus_norvegicus | Or5p66 | ENSRNOG00000009791 |
| rattus_norvegicus | Or5p59 | ENSRNOG00000028802 |
| rattus_norvegicus | Or5p78 | ENSRNOG00000034061 |
| rattus_norvegicus | Or5p81 | ENSRNOG00000055310 |
| rattus_norvegicus | Or5p78c | ENSRNOG00000074162 |
| rattus_norvegicus | Or5p60c | ENSRNOG00000075573 |
| rattus_norvegicus | Or5p58 | ENSRNOG00000075908 |
| rattus_norvegicus | Or5p50 | ENSRNOG00000076533 |
| rattus_norvegicus | Or5p69 | ENSRNOG00000078075 |
| rattus_norvegicus | Or5p76b | ENSRNOG00000081021 |
| rattus_norvegicus | Or5p60d | ENSRNOG00000081075 |
| rattus_norvegicus | ENSRNOG00000081302 | |
| rattus_norvegicus | Or5p72 | ENSRNOG00000081705 |
| rattus_norvegicus | Or5p66b | ENSRNOG00000082853 |
| rattus_norvegicus | Or5p78 | ENSRNOG00000082952 |
| rattus_norvegicus | Or5p60b | ENSRNOG00000083433 |
| rattus_norvegicus | Or5p69b | ENSRNOG00000085928 |
| rattus_norvegicus | Or5p79 | ENSRNOG00000087465 |
| rattus_norvegicus | Or5p6b | ENSRNOG00000087763 |
| rattus_norvegicus | Or5p6 | ENSRNOG00000090272 |
| rattus_norvegicus | Or5p73 | ENSRNOG00000090552 |
| rattus_norvegicus | Or5p76 | ENSRNOG00000090917 |
Paralogs (96): OR5C1 (ENSG00000148215), OR5F1 (ENSG00000149133), OR8K1 (ENSG00000150261), OR5M9 (ENSG00000150269), OR14K1 (ENSG00000153230), OR8J3 (ENSG00000167822), OR5I1 (ENSG00000167825), OR5AU1 (ENSG00000169327), OR9K2 (ENSG00000170605), OR8B12 (ENSG00000170953), OR10H3 (ENSG00000171936), OR8I2 (ENSG00000172154), OR8U1 (ENSG00000172199), OR10V1 (ENSG00000172289), OR5A1 (ENSG00000172320), OR5A2 (ENSG00000172324), OR5B12 (ENSG00000172362), OR5B2 (ENSG00000172365), OR9I1 (ENSG00000172377), OR9G4 (ENSG00000172457), OR5AR1 (ENSG00000172459), OR5AP2 (ENSG00000172464), OR8J1 (ENSG00000172487), OR5B3 (ENSG00000172769), OR10W1 (ENSG00000172772), OR5M3 (ENSG00000174937), OR5J2 (ENSG00000174957), OR10H4 (ENSG00000176231), OR5AN1 (ENSG00000176495), OR14C36 (ENSG00000177174), OR6B3 (ENSG00000178586), OR10Q1 (ENSG00000180475), OR8G2P (ENSG00000181214), OR5AK2 (ENSG00000181273), OR5AK3P (ENSG00000181282), OR5M8 (ENSG00000181371), OR8D4 (ENSG00000181518), OR8H1 (ENSG00000181693), OR8K5 (ENSG00000181752), OR8H3 (ENSG00000181761)
Protein
Protein identifiers
Olfactory receptor 5P2 — Q8WZ92 (reviewed: Q8WZ92)
Alternative names: Olfactory receptor-like protein JCG3
All UniProt accessions (2): Q8WZ92, A0A126GVJ7
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor (Potential). May be involved in taste perception.
Subcellular location. Cell membrane.
Tissue specificity. Expressed in the tongue.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_703145* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (21 total): topological domain 8, transmembrane region 7, glycosylation site 2, sequence variant 2, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WZ92-F1 | 78.97 | 0.28 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 93–185
Glycosylation sites (2): 8, 259
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 22 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_ODORANT_BINDING, CHEN_METABOLIC_SYNDROM_NETWORK, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, RAO_BOUND_BY_SALL4_ISOFORM_A, RAO_BOUND_BY_SALL4_ISOFORM_B
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), odorant binding (GO:0005549)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
270 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR5P2 | ZBED11 | P0CF97 | 477 |
| OR5P2 | F5GXT2 | F5GXT2 | 447 |
| OR5P2 | GOLGA6L10 | A6NI86 | 436 |
| OR5P2 | ANKRD45 | Q5TZF3 | 397 |
| OR5P2 | C1orf198 | Q9H425 | 395 |
| OR5P2 | ZNF99 | A8MXY4 | 394 |
| OR5P2 | TEKT5 | Q96M29 | 339 |
| OR5P2 | LRRC55 | Q6ZSA7 | 324 |
| OR5P2 | H3BVE0 | H3BVE0 | 321 |
| OR5P2 | VEPH1 | Q14D04 | 313 |
| OR5P2 | BRINP2 | Q9C0B6 | 311 |
| OR5P2 | KRT84 | Q9NSB2 | 307 |
| OR5P2 | ATP10B | O94823 | 305 |
| OR5P2 | KRT85 | P78386 | 300 |
| OR5P2 | KRT83 | P78385 | 300 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A6ND48, A6NFC9, B2RN74, O43869, O60412, O60431, P23265, P31388, P34987, P47883, P47884, P47887, P58170, Q0VAX9, Q5JRS4, Q60894, Q6IFN5, Q7Z3T1, Q8NG78, Q8NG84, Q8NG94, Q8NG99, Q8NGC0, Q8NGC1, Q8NGC5, Q8NGE7, Q8NGG2, Q8NGG3, Q8NGN1, Q8NGN2, Q8NGR1, Q8NGR2, Q8NGR6, Q8NGT2, Q8NGW1, Q8NGW6, Q8NGZ2, Q8NGZ5, Q8NH06, Q8NH07
Diamond homologs: A6NL26, O95221, P0C626, P0C7N1, P0C7N5, P0DMU2, P37070, P37071, P37072, Q13606, Q15617, Q26418, Q26419, Q60880, Q60882, Q60894, Q6IEU7, Q6IF36, Q6UXT6, Q8N127, Q8N146, Q8N162, Q8NG75, Q8NGC0, Q8NGF4, Q8NGG0, Q8NGG1, Q8NGG2, Q8NGG3, Q8NGG5, Q8NGI9, Q8NGJ0, Q8NGL0, Q8NGL1, Q8NGM9, Q8NGP2, Q8NGP4, Q8NGP6, Q8NGP9, Q8NGQ1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 3 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
116 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:7796345:C:CT | acceptor_gain | 0.9600 |
| 11:7796345:C:T | acceptor_gain | 0.9400 |
| 11:7796346:A:T | acceptor_gain | 0.8700 |
| 11:7796363:CAA:C | acceptor_gain | 0.8300 |
| 11:7796720:G:GC | acceptor_gain | 0.8300 |
| 11:7796366:C:CC | acceptor_gain | 0.7300 |
| 11:7796713:A:C | acceptor_gain | 0.7000 |
| 11:7796828:GATTA:G | donor_loss | 0.6800 |
| 11:7796829:ATTAC:A | donor_loss | 0.6800 |
| 11:7796830:TTACC:T | donor_loss | 0.6800 |
| 11:7796831:TAC:T | donor_loss | 0.6800 |
| 11:7796331:C:CT | acceptor_gain | 0.6700 |
| 11:7796720:G:C | acceptor_gain | 0.6600 |
| 11:7796827:AGATT:A | donor_loss | 0.6600 |
| 11:7796374:ACACT:A | acceptor_gain | 0.6000 |
| 11:7796536:A:AC | donor_gain | 0.6000 |
| 11:7796537:C:CC | donor_gain | 0.6000 |
| 11:7796832:A:AC | donor_gain | 0.6000 |
| 11:7796833:C:CC | donor_gain | 0.6000 |
| 11:7796712:CA:C | acceptor_gain | 0.5900 |
| 11:7796765:T:TG | acceptor_gain | 0.5900 |
| 11:7796713:A:AC | acceptor_gain | 0.5700 |
| 11:7796716:T:TC | acceptor_gain | 0.5600 |
| 11:7796535:G:T | donor_gain | 0.5500 |
| 11:7796722:G:C | acceptor_gain | 0.5400 |
| 11:7796767:A:T | acceptor_gain | 0.5400 |
| 11:7796722:G:GC | acceptor_gain | 0.5200 |
| 11:7796538:T:C | donor_gain | 0.5100 |
| 11:7796376:ACTG:A | acceptor_gain | 0.5000 |
| 11:7796766:C:CT | acceptor_gain | 0.5000 |
AlphaMissense
2106 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:7796898:G:C | F15L | 0.923 |
| 11:7796898:G:T | F15L | 0.923 |
| 11:7796900:A:G | F15L | 0.923 |
| 11:7796424:A:C | F173L | 0.889 |
| 11:7796424:A:T | F173L | 0.889 |
| 11:7796426:A:G | F173L | 0.889 |
| 11:7796850:G:C | F31L | 0.887 |
| 11:7796850:G:T | F31L | 0.887 |
| 11:7796852:A:G | F31L | 0.887 |
| 11:7796451:G:C | F164L | 0.867 |
| 11:7796451:G:T | F164L | 0.867 |
| 11:7796453:A:G | F164L | 0.867 |
| 11:7796082:G:C | S287R | 0.839 |
| 11:7796082:G:T | S287R | 0.839 |
| 11:7796084:T:G | S287R | 0.839 |
| 11:7796586:A:C | F119L | 0.827 |
| 11:7796586:A:T | F119L | 0.827 |
| 11:7796588:A:G | F119L | 0.827 |
| 11:7796421:G:C | F174L | 0.824 |
| 11:7796421:G:T | F174L | 0.824 |
| 11:7796423:A:G | F174L | 0.824 |
| 11:7796899:A:G | F15S | 0.820 |
| 11:7796306:A:G | C213R | 0.790 |
| 11:7796829:A:C | N38K | 0.789 |
| 11:7796829:A:T | N38K | 0.789 |
| 11:7796601:C:A | M114I | 0.771 |
| 11:7796601:C:G | M114I | 0.771 |
| 11:7796601:C:T | M114I | 0.771 |
| 11:7796247:C:A | K232N | 0.766 |
| 11:7796247:C:G | K232N | 0.766 |
dbSNP variants (sampled 300 via entrez): RS1000374176 (11:7798195 G>A), RS1002428144 (11:7798572 C>T), RS1003968809 (11:7797255 A>C), RS1005527151 (11:7796186 A>C), RS1005862720 (11:7798667 A>G), RS1005933787 (11:7798749 C>T), RS1008747537 (11:7795490 G>T), RS1009614049 (11:7798096 T>C), RS1009650497 (11:7798548 C>A,G,T), RS1010616638 (11:7795775 C>A,G), RS1013335990 (11:7797174 T>A), RS1013638103 (11:7797438 A>G), RS1013971613 (11:7798717 G>A,C), RS1015610106 (11:7798776 G>A,T), RS1015909653 (11:7798682 C>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010397_59 | Gut microbiota (bacterial taxa, rank normal transformation method) | 4.000000e-06 |
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| arsenite | decreases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
| Lactic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.